AbstractTo study whether treatment with the beta-blocker atenolol (AT) attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rats were treated with AT (1.5 mg · kg−1, intravenously) or saline solution (SS) prior to I (60 minutes), which was produced by occlusion of the superior mesenteric artery, and/or R (120 minutes). After I or I/R, 2-cm jejunal segments were mounted in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy analysis. Compared to the sham group, jejunal contractions were similar in the I + AT and the I/R + AT groups, but reduced in the I + SS and the I/...
BACKGROUND AND OBJECTIVES: Serious functional and structural alterations of gastrointestinal tract ...
Background: Intestinal ischemia is a highly morbid and mortal condition with no specific treatment. ...
Objectives: Adenosine and adenosine A1 receptor agonists exert protective effects against reperfusio...
To study whether treatment with the beta-blocker atenolol (AT) attenuates intestinal dysfunction cau...
Abstract Purpose: To investigate the effects of atenolol in inflammatory mediator and oxidative st...
The aim of this study was evaluate the beta blocker atenolol (AT) and ischemic preconditioning (IPC)...
Purpose: Inflammation has been shown to induce cardiac damage in multiple cardiovascular diseases pr...
In vitro studies have demonstrated that cold ischemic preservation (CIP) employed in small bowel tra...
Objetivo. Estudar o efeito do atenolol e do precondionamento isquemico no intestino delgado de ratos...
Abstract Purpose: To investigate the role of atenolol in the gene expression of caspase 1 (Casp1) ...
AbstractTo study whether treatment with heparin (HEP) attenuates intestinal dysfunction caused by is...
AbstractTo study whether ischemic preconditioning (IPC) attenuated intestinal dysfunction caused by ...
AbstractTo examine whether treatment with L-arginine (ARG), a substrate of nitric oxide biosynthesis...
To study if the treatment with adenosine (ADO), an agonist of adenosine receptors, attenuates intest...
To study whether treatment with adenosine (ADO), an agonist of adenosine receptors, attenuates intes...
BACKGROUND AND OBJECTIVES: Serious functional and structural alterations of gastrointestinal tract ...
Background: Intestinal ischemia is a highly morbid and mortal condition with no specific treatment. ...
Objectives: Adenosine and adenosine A1 receptor agonists exert protective effects against reperfusio...
To study whether treatment with the beta-blocker atenolol (AT) attenuates intestinal dysfunction cau...
Abstract Purpose: To investigate the effects of atenolol in inflammatory mediator and oxidative st...
The aim of this study was evaluate the beta blocker atenolol (AT) and ischemic preconditioning (IPC)...
Purpose: Inflammation has been shown to induce cardiac damage in multiple cardiovascular diseases pr...
In vitro studies have demonstrated that cold ischemic preservation (CIP) employed in small bowel tra...
Objetivo. Estudar o efeito do atenolol e do precondionamento isquemico no intestino delgado de ratos...
Abstract Purpose: To investigate the role of atenolol in the gene expression of caspase 1 (Casp1) ...
AbstractTo study whether treatment with heparin (HEP) attenuates intestinal dysfunction caused by is...
AbstractTo study whether ischemic preconditioning (IPC) attenuated intestinal dysfunction caused by ...
AbstractTo examine whether treatment with L-arginine (ARG), a substrate of nitric oxide biosynthesis...
To study if the treatment with adenosine (ADO), an agonist of adenosine receptors, attenuates intest...
To study whether treatment with adenosine (ADO), an agonist of adenosine receptors, attenuates intes...
BACKGROUND AND OBJECTIVES: Serious functional and structural alterations of gastrointestinal tract ...
Background: Intestinal ischemia is a highly morbid and mortal condition with no specific treatment. ...
Objectives: Adenosine and adenosine A1 receptor agonists exert protective effects against reperfusio...